Your browser doesn't support javascript.
loading
Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvß3 and down-regulating tetraspanin CD9.
Yin, Miao; Soikkeli, Johanna; Jahkola, Tiina; Virolainen, Susanna; Saksela, Olli; Hölttä, Erkki.
Affiliation
  • Yin M; Department of Pathology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Soikkeli J; Department of Pathology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Jahkola T; Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, Finland.
  • Virolainen S; Department of Pathology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Saksela O; Department of Dermatology, Helsinki University Central Hospital, Helsinki, Finland.
  • Hölttä E; Department of Pathology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. Electronic address: erkki.holtta@helsinki.fi.
Am J Pathol ; 184(3): 842-58, 2014 Mar.
Article in En | MEDLINE | ID: mdl-24412090
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Vitronectin / Integrin alphaVbeta3 / Osteopontin / Tetraspanin 29 / Melanoma Limits: Humans Language: En Journal: Am J Pathol Year: 2014 Type: Article Affiliation country: Finland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Vitronectin / Integrin alphaVbeta3 / Osteopontin / Tetraspanin 29 / Melanoma Limits: Humans Language: En Journal: Am J Pathol Year: 2014 Type: Article Affiliation country: Finland